PT84126B - Processo para a preparacao de beta2-microglobulinas modificadas - Google Patents

Processo para a preparacao de beta2-microglobulinas modificadas

Info

Publication number
PT84126B
PT84126B PT84126A PT8412687A PT84126B PT 84126 B PT84126 B PT 84126B PT 84126 A PT84126 A PT 84126A PT 8412687 A PT8412687 A PT 8412687A PT 84126 B PT84126 B PT 84126B
Authority
PT
Portugal
Prior art keywords
ser
lys
asp
beta
glu
Prior art date
Application number
PT84126A
Other languages
English (en)
Other versions
PT84126A (en
Inventor
Jesper Zeuthen
Flemming Stig Larsen
Lars Thim
Mogens Christensen
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of PT84126A publication Critical patent/PT84126A/pt
Publication of PT84126B publication Critical patent/PT84126B/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/811—Peptides or proteins is immobilized on, or in, an inorganic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PT84126A 1986-01-16 1987-01-16 Processo para a preparacao de beta2-microglobulinas modificadas PT84126B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK021586A DK160944C (da) 1986-01-16 1986-01-16 Modificerede beta2-mikroglobuliner og farmaceutiske praeparater indeholdende disse

Publications (2)

Publication Number Publication Date
PT84126A PT84126A (en) 1987-02-01
PT84126B true PT84126B (pt) 1989-09-14

Family

ID=8091032

Family Applications (1)

Application Number Title Priority Date Filing Date
PT84126A PT84126B (pt) 1986-01-16 1987-01-16 Processo para a preparacao de beta2-microglobulinas modificadas

Country Status (8)

Country Link
US (1) US5051371A (pt)
EP (1) EP0229723A3 (pt)
JP (1) JPS62246596A (pt)
AU (1) AU601963B2 (pt)
DK (1) DK160944C (pt)
FI (1) FI870160A (pt)
NO (1) NO870174L (pt)
PT (1) PT84126B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0375740A1 (en) * 1987-09-04 1990-07-04 Whitehead Institute For Biomedical Research Peptide complexes having enhanced stability
FR2735984B1 (fr) * 1995-06-30 1997-09-19 Inst Nat Sante Rech Med Vaccin contre des agents infectieux ayant une phase intracellulaire, composition pour le traitement et la prevention des infections a hiv, anticorps et procede de diagnostic
GB9929993D0 (en) * 1999-12-17 2000-02-09 Avidex Ltd Substances
MXPA05005031A (es) * 2002-11-12 2005-11-17 Becton Dickinson Co Diagnostico de la sepsis o sirs usando perfiles de biomarcadores.
WO2005063335A2 (en) * 2003-12-30 2005-07-14 Statens Serum Institut MONOCLONAL DES-LYS58-β2-MICROGLOBULIN ANTIBODIES FOR MEASUREMENT AND MANAGEMENT OF HEMODIALYSIS COMPLICATIONS
CA2605143A1 (en) 2005-04-15 2006-10-26 Becton, Dickinson And Company Diagnosis of sepsis
WO2009123737A2 (en) 2008-04-03 2009-10-08 Becton, Dickinson And Company Advanced detection of sepsis
JP2012242170A (ja) * 2011-05-17 2012-12-10 Tosoh Corp 測定容器

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
JPS5530652A (en) * 1978-08-28 1980-03-04 Seikagaku Kogyo Co Ltd Latex sensitive to antibody of human beta2-microglobulin for quantitizing human beta2-microglobulin and its composite

Also Published As

Publication number Publication date
JPS62246596A (ja) 1987-10-27
AU601963B2 (en) 1990-09-27
DK160944B (da) 1991-05-06
DK21586D0 (da) 1986-01-16
DK21586A (da) 1987-09-14
US5051371A (en) 1991-09-24
FI870160A0 (fi) 1987-01-15
EP0229723A2 (en) 1987-07-22
EP0229723A3 (en) 1990-05-23
AU6763987A (en) 1987-07-23
NO870174L (no) 1987-07-17
FI870160A (fi) 1987-07-17
NO870174D0 (no) 1987-01-15
PT84126A (en) 1987-02-01
DK160944C (da) 1991-10-21

Similar Documents

Publication Publication Date Title
EP0004940B1 (de) Verfahren zur radioimmunologischen Bestimmung von Prokollagen (Typ III) und Prokollagen-Peptid (Typ III), zur Herstellung von für das Verfahren geeignetem Prokollagen-Peptid (Typ III) und zur Herstellung von Anti-Prokollagen-Peptid (Typ III)-Serum
US3822245A (en) Opium alkaloid specific antibodies
BR0014252A (pt) Nanopartìculas magnéticas tendo atividade bioquìmica, método para sua produção e seus usos
PT87797A (pt) Process for the production of copolymer thickeners in aqueous emulsion with carboxyl-functional soluble in alkalis
Schmidt Group A streptococcus polysaccharide: studies on its preparation, chemical composition, and cellular localization after intravenous injection into mice
BR1100843A (pt) Mak 195, linha celular hìbrida, processo de preparação de anticorpos monoclonais mak 195, aplicação do anticorpo monoclonal mak 195
DE69429999D1 (de) Verfahren zur herstellung von diagnostischen reagentien, testverfahren und medikamenten, die auf den klinischen manifestationen einer krankheit beruhen
PT84126B (pt) Processo para a preparacao de beta2-microglobulinas modificadas
Kabat et al. Preparation of the type-specific polysaccharide of the type I meningococcus and a study of its effectiveness as an antigen in human beings
ES512498A0 (es) "metodo y su correspondiente aparato para el ensayo de anticuerpos con respecto a antigenos solubles".
ES2032447T3 (es) Nuevos anticuerpos monoclonales y su produccion y uso.
ATE7761T1 (de) Impfstoff und herstellungsverfahren.
ATE26279T1 (de) Verfahren zur isolierung und reinigung von antibiotika.
DE4240056A1 (de) Streptolysin O Peptidantigene und Verfahren zur Bestimmung von Streptolysin-Antikörper
DE69027221D1 (de) Substituierte 4-phenyl-4-piperidincarboxamide mit sowohl lokalanästhetischer als auch schmerzlindernder wirkung sowie verfahren zur herstellung
EP0287076B1 (de) Rezeptor der Kleinen Rhinovirus Rezeptor Gruppe
Heidelberger et al. Serological reactivity of synthetic polyglucoses
KR860007286A (ko) Grf 유도체의 제조방법
ATE185150T1 (de) Proteinkomplex
Affronti et al. Some early investigations of Mycobacterium tuberculosis
DK479687A (da) Antistoffer mod modificeret beta2-mikroglobulin samt diagnostika og praeparater indeholdende disse
DE3231204A1 (de) Antikoerper gegen bakterielle peptidoglycane, verfahren zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
SE8904007D0 (sv) Monoklona antikroppar och diagnostiseringsmetod
AU4411093A (en) Haptens, tracers, immunogens and antibodies for 3-phenyl-1-adamantaneacetic acids
PT88913A (pt) Processo para a preparacao da proteina pp4-x anticoagulante

Legal Events

Date Code Title Description
MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19940831